PhaseV (Series A)
Funding Details
Awarder
RSS - theaiinsider.tech
Date Award
May 17, 2025
Vertical
AI/ML-driven clinical development
Funding URL
View Funding Page
Funding Amount
$50,000,000
Company Info
Traction
Used by over 30 global pharma companies across 20+ therapeutic areas, reducing trial costs by 50%, shortening duration by 40%, and boosting success rates by over 30%.
Organizations Involved
30 global pharma companies
Founders
Raviv Pryluk
Market
Pharmaceuticals and Biotechnology
Location
USA
Coinvestors
Accel, Insight Partners, Viola Ventures, EXOR, LionBird
Company Description

PhaseV provides AI-driven solutions for efficient clinical development and operations.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to AI/ML-driven clinical development DealsView Funding Announcement